{
    "2021-01-20": [
        [
            {
                "time": "",
                "orginal_text": "3个⽉仓位猛打⾄90%！知名基⾦经理调仓动向曝光",
                "features": {
                    "keywords": [
                        "仓位",
                        "90%",
                        "基金经理",
                        "调仓"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "【今日机构评级汇总】小摩认为Roku能抓住更多“重⼤”广告机会；杰富瑞看好理想汽车对动⼒系统的选择",
                "features": {
                    "keywords": [
                        "Roku",
                        "广告机会",
                        "理想汽车",
                        "动力系统"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "汽车"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "医药股表现强势，“两定”新规将施行，利好龙头连锁药店",
                "features": {
                    "keywords": [
                        "医药股",
                        "两定新规",
                        "连锁药店"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "临床阶段⽣物技术公司天演药业(ADAG.US)赴美上市，药明康德(02359)持股⽐例达10.8%",
                "features": {
                    "keywords": [
                        "天演药业",
                        "药明康德",
                        "赴美上市"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "花旗：首予药明康德(02359)目标价236港元 评级“买入”",
                "features": {
                    "keywords": [
                        "花旗",
                        "药明康德",
                        "买入",
                        "目标价"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医药生物⾏业报告：中外新冠疫苗PK 孰优孰劣？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "新冠疫苗",
                        "PK"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "解盘：⼩⾦属整体活跃，稀土、动⼒电池、电源设备领涨",
                "features": {
                    "keywords": [
                        "小金属",
                        "稀土",
                        "动力电池",
                        "电源设备"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "材料",
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "CXO公司市值暴涨，药明康德接近4000亿；做药or卖水？摆在⽼板⾯前的选择题",
                "features": {
                    "keywords": [
                        "CXO",
                        "药明康德",
                        "市值暴涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "药明康德冲击涨停，股价创历史新高",
                "features": {
                    "keywords": [
                        "药明康德",
                        "涨停",
                        "股价新高"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "【异动股】药明康德(02359-HK)涨6.23%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "异动股",
                        "涨6.23%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医药股持续⾛强，泰格医药、康龙化成涨逾10%",
                "features": {
                    "keywords": [
                        "医药股",
                        "泰格医药",
                        "康龙化成",
                        "涨逾10%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "52只股北向资⾦持有流通盘的⽐例超10%",
                "features": {
                    "keywords": [
                        "北向资金",
                        "流通盘",
                        "比例超10%"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "策略专题报告：“需求侧管理与消费升级”投资机会挖掘电话会议纪要",
                "features": {
                    "keywords": [
                        "需求侧管理",
                        "消费升级",
                        "投资机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}